Report cover image

Global Nervous System Medications Market Growth 2023-2029

Publisher LP Information, Inc.
Published Jun 16, 2023
Length 100 Pages
SKU # LPI18012193

Description

Global Nervous System Medications Market Growth 2023-2029


The global Nervous System Medications market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Nervous System Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Nervous System Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Nervous System Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Nervous System Medications players cover Pfizer, Teva, Novartis, AstraZeneca, Takeda, Johnson & Johnson, EliLilly, Otsuka and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Nervous System Medications Industry Forecast” looks at past sales and reviews total world Nervous System Medications sales in 2022, providing a comprehensive analysis by region and market sector of projected Nervous System Medications sales for 2023 through 2029. With Nervous System Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nervous System Medications industry.

This Insight Report provides a comprehensive analysis of the global Nervous System Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nervous System Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nervous System Medications market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nervous System Medications and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nervous System Medications.

This report presents a comprehensive overview, market shares, and growth opportunities of Nervous System Medications market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Anesthetic
Painkiller
Psychostimulants
Antiepileptic Drugs
Anti-Parkinson Drugs
Others

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Teva
Novartis
AstraZeneca
Takeda
Johnson & Johnson
EliLilly
Otsuka
Merck
Yangtze River Pharmaceutical
Humanwell Healthcare
CSPC-NBP Pharmaceutical
Nhwa Pharmaceutical
Qilu Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nervous System Medications market?

What factors are driving Nervous System Medications market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nervous System Medications market opportunities vary by end market size?

How does Nervous System Medications break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

100 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nervous System Medications Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nervous System Medications by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nervous System Medications by Country/Region, 2018, 2022 & 2029
2.2 Nervous System Medications Segment by Type
2.2.1 Anesthetic
2.2.2 Painkiller
2.2.3 Psychostimulants
2.2.4 Antiepileptic Drugs
2.2.5 Anti-Parkinson Drugs
2.2.6 Others
2.3 Nervous System Medications Sales by Type
2.3.1 Global Nervous System Medications Sales Market Share by Type (2018-2023)
2.3.2 Global Nervous System Medications Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nervous System Medications Sale Price by Type (2018-2023)
2.4 Nervous System Medications Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Nervous System Medications Sales by Application
2.5.1 Global Nervous System Medications Sale Market Share by Application (2018-2023)
2.5.2 Global Nervous System Medications Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nervous System Medications Sale Price by Application (2018-2023)
3 Global Nervous System Medications by Company
3.1 Global Nervous System Medications Breakdown Data by Company
3.1.1 Global Nervous System Medications Annual Sales by Company (2018-2023)
3.1.2 Global Nervous System Medications Sales Market Share by Company (2018-2023)
3.2 Global Nervous System Medications Annual Revenue by Company (2018-2023)
3.2.1 Global Nervous System Medications Revenue by Company (2018-2023)
3.2.2 Global Nervous System Medications Revenue Market Share by Company (2018-2023)
3.3 Global Nervous System Medications Sale Price by Company
3.4 Key Manufacturers Nervous System Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nervous System Medications Product Location Distribution
3.4.2 Players Nervous System Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nervous System Medications by Geographic Region
4.1 World Historic Nervous System Medications Market Size by Geographic Region (2018-2023)
4.1.1 Global Nervous System Medications Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nervous System Medications Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nervous System Medications Market Size by Country/Region (2018-2023)
4.2.1 Global Nervous System Medications Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nervous System Medications Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nervous System Medications Sales Growth
4.4 APAC Nervous System Medications Sales Growth
4.5 Europe Nervous System Medications Sales Growth
4.6 Middle East & Africa Nervous System Medications Sales Growth
5 Americas
5.1 Americas Nervous System Medications Sales by Country
5.1.1 Americas Nervous System Medications Sales by Country (2018-2023)
5.1.2 Americas Nervous System Medications Revenue by Country (2018-2023)
5.2 Americas Nervous System Medications Sales by Type
5.3 Americas Nervous System Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nervous System Medications Sales by Region
6.1.1 APAC Nervous System Medications Sales by Region (2018-2023)
6.1.2 APAC Nervous System Medications Revenue by Region (2018-2023)
6.2 APAC Nervous System Medications Sales by Type
6.3 APAC Nervous System Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nervous System Medications by Country
7.1.1 Europe Nervous System Medications Sales by Country (2018-2023)
7.1.2 Europe Nervous System Medications Revenue by Country (2018-2023)
7.2 Europe Nervous System Medications Sales by Type
7.3 Europe Nervous System Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nervous System Medications by Country
8.1.1 Middle East & Africa Nervous System Medications Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nervous System Medications Revenue by Country (2018-2023)
8.2 Middle East & Africa Nervous System Medications Sales by Type
8.3 Middle East & Africa Nervous System Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nervous System Medications
10.3 Manufacturing Process Analysis of Nervous System Medications
10.4 Industry Chain Structure of Nervous System Medications
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nervous System Medications Distributors
11.3 Nervous System Medications Customer
12 World Forecast Review for Nervous System Medications by Geographic Region
12.1 Global Nervous System Medications Market Size Forecast by Region
12.1.1 Global Nervous System Medications Forecast by Region (2024-2029)
12.1.2 Global Nervous System Medications Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nervous System Medications Forecast by Type
12.7 Global Nervous System Medications Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Nervous System Medications Product Portfolios and Specifications
13.1.3 Pfizer Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Nervous System Medications Product Portfolios and Specifications
13.2.3 Teva Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Nervous System Medications Product Portfolios and Specifications
13.3.3 Novartis Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Nervous System Medications Product Portfolios and Specifications
13.4.3 AstraZeneca Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Nervous System Medications Product Portfolios and Specifications
13.5.3 Takeda Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Nervous System Medications Product Portfolios and Specifications
13.6.3 Johnson & Johnson Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 EliLilly
13.7.1 EliLilly Company Information
13.7.2 EliLilly Nervous System Medications Product Portfolios and Specifications
13.7.3 EliLilly Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 EliLilly Main Business Overview
13.7.5 EliLilly Latest Developments
13.8 Otsuka
13.8.1 Otsuka Company Information
13.8.2 Otsuka Nervous System Medications Product Portfolios and Specifications
13.8.3 Otsuka Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Otsuka Main Business Overview
13.8.5 Otsuka Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Nervous System Medications Product Portfolios and Specifications
13.9.3 Merck Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Yangtze River Pharmaceutical
13.10.1 Yangtze River Pharmaceutical Company Information
13.10.2 Yangtze River Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.10.3 Yangtze River Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Yangtze River Pharmaceutical Main Business Overview
13.10.5 Yangtze River Pharmaceutical Latest Developments
13.11 Humanwell Healthcare
13.11.1 Humanwell Healthcare Company Information
13.11.2 Humanwell Healthcare Nervous System Medications Product Portfolios and Specifications
13.11.3 Humanwell Healthcare Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Humanwell Healthcare Main Business Overview
13.11.5 Humanwell Healthcare Latest Developments
13.12 CSPC-NBP Pharmaceutical
13.12.1 CSPC-NBP Pharmaceutical Company Information
13.12.2 CSPC-NBP Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 CSPC-NBP Pharmaceutical Main Business Overview
13.12.5 CSPC-NBP Pharmaceutical Latest Developments
13.13 Nhwa Pharmaceutical
13.13.1 Nhwa Pharmaceutical Company Information
13.13.2 Nhwa Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.13.3 Nhwa Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Nhwa Pharmaceutical Main Business Overview
13.13.5 Nhwa Pharmaceutical Latest Developments
13.14 Qilu Pharma
13.14.1 Qilu Pharma Company Information
13.14.2 Qilu Pharma Nervous System Medications Product Portfolios and Specifications
13.14.3 Qilu Pharma Nervous System Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Qilu Pharma Main Business Overview
13.14.5 Qilu Pharma Latest Developments
14 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us